CTBP2 Antikörper (AA 1-445)
Kurzübersicht für CTBP2 Antikörper (AA 1-445) (ABIN560519)
Target
Alle CTBP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-445
-
Verwendungszweck
- Mouse polyclonal antibody raised against a full-length recombinant CTBP2.
-
Sequenz
- MALVDKHKVK RQRLDRICEG IRPQIMNGPL HPRPLVALLD GRDCTVEMPI LKDLATVAFC DAQSTQEIHE KVLNEAVGAM MYHTITLTRE DLEKFKALRV IVRIGSGYDN VDIKAAGELG IAVCNIPSAA VEETADSTIC HILNLYRRNT WLYQALREGT RVQSVEQIRE VASGAARIRG ETLGLIGFGR TGQAVAVRAK AFGFSVIFYD PYLQDGIERS LGVQRVYTLQ DLLYQSDCVS LHCNLNEHNH HLINDFTIKQ MRQGAFLVNA ARGGLVDEKA LAQALKEGRI RGAALDVHES EPFSFAQGPL KDAPNLICTP HTAWYSEQAS LEMREAAATE IRRAITGRIP ESLRNCVNKE FFVTSAPWSV IDQQAIHPEL NGATYRYPPG IVGVAPGGLP AAMEGIIPGG IPVTHNLPTV AHPSQAPSPN QPTKHGDNRE HPNEQ
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- CTBP2 (AAH02486, 1 a.a. ~ 445 a.a) full-length recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Expression patterns of candidate susceptibility genes HNF1? and CtBP2 in prostate cancer: association with tumor progression." in: Urologic oncology, Vol. 32, Issue 4, pp. 426-32, (2014) (PubMed).
: "
-
Expression patterns of candidate susceptibility genes HNF1? and CtBP2 in prostate cancer: association with tumor progression." in: Urologic oncology, Vol. 32, Issue 4, pp. 426-32, (2014) (PubMed).
-
- CTBP2 (C-terminal Binding Protein 2 (CTBP2))
-
Andere Bezeichnung
- CTBP2
-
Hintergrund
-
Full Gene Name: C-terminal binding protein 2
Synonyms: -
Gen-ID
- 1488
Target
-